New funding awards - March 2020

Friday, April 24, 2020

Sponsored Research

Adam Devore of Cardiology has received an award from the American Heart Association for a project entitled "Get With The Guidelines (GWTG) Task Order #26." Total funding will be $30,000.

Martin Moseley III of Cardiology has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Proteomics & Metabolomics Core." Total funding will be $87,016.

Bruce Burnett of Clinical Pharmacology has received an award from the Stanford University for a project entitled "Consultation for the Stanford Microbiome Therapies Initiative." Total funding will be $38,859.

Mark Herman of Endocrinology has received an award (2R01-DK100425-07A1) from the National Institutes of Health for a project entitled "The Role of ChREBP in Fructose Induced Metabolic Disease." Total funding will be $1,807,272.

Winston W. Liu (Mentor: Rodger Liddle) of Gastroenterology has received an award (1F30-DK122712-01A1) from the National Institutes of Health for a project entitled "Neural sensing of gut bacteria." Total funding will be $1,121,544.

Jatin Roper of Gastroenterology has received an award from the Elsa U. Pardee Foundation for a project entitled "Immune surveillance in obesity-associated cancer." Total funding will be $174,925.

Lori Orlando of General Internal Medicine has received a sub-award (1U01-CA232829-01A1) through the Vanderbilt University Medical Center for a project entitled "Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform." Total funding will be $293,793.

Kimberly Johnson of Geriatrics has received an award from the Arthur Vining Davis Foundations for a project entitled "Advancing Health Equity: Development and Implementation of a Faith-Based Model across a Network of Churches to Reduce Disparities in Palliative Care for African Americans through Education." Total funding will be $306,600.

Nelson Chao of Hematologic Malignancies and Cellular Therapy has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Hematologic Malignancies Program." Total funding will be $70,715.

Nelson Chao of Hematologic Malignancies and Cellular Therapy has received a sub-award (N00014-17-1-2388) through the National Marrow Donor Program for a project entitled "RITN 2020." Total funding will be $8,000.

Sandeep Dave of Hematologic Malignancies and Cellular Therapy has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Cancer Genetics and Genomics Program." Total funding will be $79,254.

Deverick Anderson of Infectious Diseases has received an award (CDC-75D30118F00002) from the Centers for Disease Control and Prevention for a project entitled "RFTOP #2018 Domain 2-B-0001 Option 1." Total funding will be $577,784.

Deverick Anderson of Infectious Diseases has received a sub-award (2UM-1A104681-00) through the National Institutes of Health for a project entitled "Consortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae (CRACKLE): a Prospective, Observational Cohort Study (2UM1AI104681-08) Duke Site #0018." Total funding will be $0.

James Abbruzzese of Medical Oncology has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Protocol Review and Monitoring System." Total funding will be $198,347.

James Abbruzzese of Medical Oncology has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Clinical Protocol and Data Management." Total funding will be $175,118.

Gerard Blobe of Medical Oncology has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Cancer Research Career Enhancement and Related Activities." Total funding will be $241,500.

Gerard Blobe of Medical Oncology has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Solid Tumor Program." Total funding will be $77,986.

Steven Patierno of Medical Oncology has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Community Outreach and Engagement." Total funding will be $241,500.

Ivan Spasojevic of Medical Oncology has received an award (2P30-CA014236-46) from the National Institutes of Health for a project entitled "Pharmacokinetics Core." Total funding will be $145,719.

Loretta Que of Pulmonary has received an award from the American Lung Association for a project entitled "American Lung Association (ALA) Novel Digital Diary (ANDDI) Trial." Total funding will be $1.

William St Clair of Rheumatology has received a sub-award (5UM1-AI109565-07) through the Benaroya Research Institute at Virginia Mason for a project entitled "Subaward Agreement - Benaroya to Duke - ITN Network Deputy Director of Clinical Affairs." Total funding will be $148,791.

Industry-sponsored Clinical Trials

Sana Al-Khatib of Cardiology has received an award from Medtronic, Inc. for a project entitled "INSPIRE." Total funding will be $99,943.

Brett Atwater of Cardiology has received an award from Medtronic, Inc. for a project entitled "ExtraVascular Implantable Cardioverter Defibrillator (EVICD) Pivotal Study." Total funding will be $246,122.

Michel Khouri of Cardiology has received an award from Alnylam Pharmaceuticals for a project entitled "Helios-B: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Outcomes, Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR amyloidosis with cardiomyopathy)." Total funding will be $835,932.

Renato Lopes of Cardiology has received an award from GlaxoSmithKline for a project entitled "MACE COMMITTEE COLLABORATION LOI." Total funding will be $290,242.

Robert Mentz of Cardiology has received an award from Bayer Pharmaceuticals for a project entitled "Prognostic value of Heart Rate Variability measured by Cardiovascular Implantable Electronic Devices." Total funding will be $170,964.

Neha Pagidipati of Cardiology has received an award from Amgen, Inc. for a project entitled "Characterization of Lp(a) Testing in a Network Consortium." Total funding will be $614,204.

Kishan Parikh of Cardiology has received an award from Complexa, Inc for a project entitled "Complexa Prime Open Label extention." Total funding will be $77,132.

Jonathan Piccini of Cardiology has received an award from Biotronik, Inc. for a project entitled "HUMAN USE CONDITION STUDY ASSOCIATION FOR ADVANCEMENT OF MEDICAL INSTRUMENTATION FLUOROSCOPIC EVALUATION OF 3D CURVATURE OF IMPLANTED LEADS IN HUMANS." Total funding will be $845,662.

Jatin Roper of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Gilead Sponsored Research Agreement." Total funding will be $849,592.

Lindsay Rein of Hematologic Malignancies and Cellular Therapy has received an award from Boston Biomedical, Inc. for a project entitled "BBI Ph1 TP-3654 and Ruxolitinb in patients with Intermediate and High Risk Myelofibrosis." Total funding will be $390,274.

Dorothy Sipkins of Hematologic Malignancies and Cellular Therapy has received an award from GlycoMimetics, Inc for a project entitled "Studying the Effects of Combined E-selectin and CXCR4 Inhibition on Breast Cancer Cell Immune Recognition." Total funding will be $155,486.

Cameron Wolfe of Infectious Diseases has received a sub-award (75N91019D00024) through Leidos Biomedical Research, Inc. for a project entitled "Adaptive COVID-19 Treatment Trial (ACTT)." Total funding will be $139,999.

Andrew Nixon of Medical Oncology has received an award from Seattle Genetics, Inc for a project entitled "Mountaineer Biomarker Study: A Phase II, Open Label Study of Tucatinib Combined with Trastuzumab in Patients with HET2+ Metastatic Colorectal Cancer.." Total funding will be $189,846.

Richard Riedel of Medical Oncology has received an award from GlaxoSmithKline for a project entitled "Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered NY-ESO-1-Specific (c259) T Cells, alone or in combination with other agents, in HLA-A2+ Participants with NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO)." Total funding will be $1,662,241.

Tian Zhang of Medical Oncology has received an award from AstraZeneca LP for a project entitled ""A Phase 1b Study of Durvalumab plus Tremelimumab followed by Concurrent Durvalumab plus Bladder-Sparing Radiation, based on Molecular Subtypes in  Muscle-Invasive Bladder Cancer"." Total funding will be $25,000.

Opeyemi Olabisi of Nephrology has received an award from Vertex Pharmaceuticals Inc. for a project entitled "A Natural History Study of Patients With Biopsy-proven Focal Segmental Glomerulosclerosis and Nephrotic Range Proteinuria Who Are of Recent African Ancestry or Have 2 APOL1 Risk Alleles." Total funding will be $62,861.

Peter Bressler of Pulmonary has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "AZ Natron D3254C00001: A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 24-week Phase 3 Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizum." Total funding will be $287,343.

Timothy McMahon of Pulmonary has received an award from Hemanext for a project entitled "Influence of anaerobic RBC storage on RBC ATP export." Total funding will be $80,497.

William St Clair of Rheumatology has received an award from Viela Bio, Inc. for a project entitled "A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VIB4920 IN SUBJECTS WITH SJOGREN'S SYNDROME (SS)." Total funding will be $162,047.